ArticleRheumatology and therapy2026

Efficacy and Safety of Firsekibart in Treatment of Active Systemic Juvenile Idiopathic Arthritis: A Randomized Phase 2 Study.

Caifeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.